Clorox Co. (CLX) Reports Strong Q2 Results; Boosts FY12 Revs Growth Outlook
Tweet
Share
E-mail
Get Alerts CLX Hot Sheet
Price: $91.60 -1.57%
EPS Growth %: +30.6%
Financial Fact:
Selling and administrative expenses: 200M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +30.6%
Financial Fact:
Selling and administrative expenses: 200M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Clorox Co. (NYSE: CLX) reported Q2 non-GAAP EPS of $0.82, which may not compare to the analyst estimate of $0.68. Excluding impairment charges, the number was 79 cents. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.2 billion.
Clorox now anticipates sales growth for fiscal year 2012 in the range of 2 percent to 4 percent, versus the company's previous outlook of 1 percent to 3 percent growth.
For earnings history and earnings-related data on Clorox Co. (CLX) click here.
Clorox now anticipates sales growth for fiscal year 2012 in the range of 2 percent to 4 percent, versus the company's previous outlook of 1 percent to 3 percent growth.
For earnings history and earnings-related data on Clorox Co. (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
- BMO Capital Starts Lululemon (LULU) at Underperform
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
